Search Results - "ANDRE, Amy K"
-
1
Dose-Ranging Study of the Safety and Pharmacokinetics of Atrasentan in Patients with Refractory Malignancies
Published in Clinical cancer research (01-07-2004)“…Purpose: Atrasentan is an orally bioavailable selective antagonist of the endothelin receptor ET A . Due to the potential activity of this agent against…”
Get full text
Journal Article -
2
The effect of hepatic insufficiency on the safety and pharmacokinetics of paricalcitol (Zemplar)
Published in Nephron. Clinical practice (01-01-2006)“…Paricalcitol is highly protein bound, extensively metabolized and eliminated primarily by hepatobiliary excretion. This study was designed to determine if…”
Get more information
Journal Article